Towards an inter-university partnership with VIVES to strengthen the financing of spin-off

On the occasion of the Royal Visit to the Grand Duchy of Luxembourg, the UCLouvain announces that the Université du Luxembourg, the Fonds National de la Recherche and the Luxembourg Institute of Healthhave signed a letter of interest to establish partnershipsin the framework of the launch of the new «VIVES Inter-University Fund».

Story image

 

This new fund, which ultimately targets a size of around 50 million euros, aims to translate the results of cutting-edge European scientific research into entrepreneurial projects with a high potential and strong societal impact.

VIVES Inter-University Fund will be able to invest from the creation of the spin-offsand up to 5 million euros in a file

Press Release downlodable below.

 


Press Release VIVES Luxembourg CP-VIVES-Royal Visit-EN.pdf - 892 KB

 

 

About Vives

VIVES Inter-University Fund is a multi-sectorial technology fund that invests in projects with significant societal impact. With €32M, it has the capacity to invest during the different development stages of a company: seed, start-up and growth. The fund can support spin-offs of UCLouvain or of its partner universities - KULeuven (BE), Université de Paris Diderot Descartes (FR), Wageningen Universiteit (NL), Université du Luxembourg (LU) – as well as in start-ups located within 400 kilometres from Louvain-la-Neuve. VIVES is managed by Sopartec, the technology transfer office of UCLouvain. Key portfolio companies are amongst others: iTeos, Novadip, Tessares, Axinesis, Botalys, Upstreem, Virovet, E-Peas, Aphea, Virovet, etc.

Vives
Bâtiment Le Parc
Place de l’Université 16 bte 27
1348 Louvain-la-Neuve
Belgium